Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Land Og By Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   27.9% 13.5% 12.6% 9.3% 6.6% 4.3% 13.4% 12.8%   Credit score (0-100)   3 18 18 25 36 47 17 18   Credit rating   B BB BB BB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   831 899 1,725 2,146 2,401 2,371 0.0 0.0   EBITDA   -357 -73.0 -36.2 257 762 600 0.0 0.0   EBIT   -357 -73.0 -81.5 169 594 387 0.0 0.0   Pre-tax profit (PTP)   -358.9 -87.8 -88.6 160.6 578.3 366.1 0.0 0.0   Net earnings   -358.9 -87.8 -88.6 160.6 511.9 270.0 0.0 0.0   Pre-tax profit without non-rec. items   -359 -87.8 -88.6 161 578 366 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 128 404 426 526 555 0.0 0.0   Shareholders equity total   -359 -447 -535 -335 177 447 407 407   Interest-bearing liabilities   52.0 305 324 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9.8 215 594 1,022 1,470 1,588 407 407   Net Debt   52.0 287 251 -125 -80.0 -114 -263 -263     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   831 899 1,725 2,146 2,401 2,371 0.0 0.0   Gross profit growth   0.0% 8.1% 92.0% 24.4% 11.8% -1.2% -100.0% 0.0%   Employees   0 3 4 5 5 5 0 0   Employee growth %   0.0% 0.0% 33.3% 25.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10 215 594 1,022 1,470 1,588 407 407   Balance sheet change%   0.0% 2,105.9% 175.9% 72.1% 43.8% 8.0% -74.4% 0.0%   Added value   -357.3 -73.0 -36.2 256.9 682.2 600.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 128 231 98 -40 -231 -555 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -43.0% -8.1% -4.7% 7.9% 24.8% 16.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -96.6% -13.5% -9.0% 13.6% 42.0% 25.3% 0.0% 0.0%   ROI %   -684.6% -39.0% -25.5% 104.3% 581.8% 114.8% 0.0% 0.0%   ROE %   -3,678.2% -78.0% -21.9% 19.9% 85.4% 86.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -97.4% -67.5% -47.4% -24.7% 12.1% 28.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -14.6% -393.5% -692.1% -48.5% -10.5% -19.1% 0.0% 0.0%   Gearing %   -14.5% -68.3% -60.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.0% 10.1% 2.6% 5.2% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.1 0.2 0.3 0.6 0.8 0.0 0.0   Current Ratio   0.0 0.1 0.2 0.3 0.6 0.8 0.0 0.0   Cash and cash equivalent   0.0 17.8 73.4 124.5 80.0 114.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -358.9 -574.7 -939.4 -924.8 -513.3 -228.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -24 -9 51 136 120 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -24 -9 51 152 120 0 0   EBIT / employee   0 -24 -20 34 119 77 0 0   Net earnings / employee   0 -29 -22 32 102 54 0 0